{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~6 mi. (Kennebunk, Maine, +825 more cities)
facility
Maine Center for Cancer Medicine-Kennebunk
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~6 mi. (Kennebunk, Maine, +954 more cities)
facility
Maine Center for Cancer Medicine-Kennebunk
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~16 mi. (Sanford, Maine, +523 more cities)
facility
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~16 mi. (Sanford, Maine, +454 more cities)
facility
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
city
~16 mi. (Sanford, Maine, +240 more cities)
facility
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford
condition
Endometrial Adenocarcinoma, +5 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type